rs755117226
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_021871.4(FGA):c.502C>T(p.Arg168Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000149 in 1,613,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000014 ( 0 hom. )
Consequence
FGA
NM_021871.4 stop_gained
NM_021871.4 stop_gained
Scores
2
3
2
Clinical Significance
Conservation
PhyloP100: 3.77
Genes affected
FGA (HGNC:3661): (fibrinogen alpha chain) This gene encodes the alpha subunit of the coagulation factor fibrinogen, which is a component of the blood clot. Following vascular injury, the encoded preproprotein is proteolytically processed by thrombin during the conversion of fibrinogen to fibrin. Mutations in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia, afibrinogenemia and renal amyloidosis. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that undergoes proteolytic processing. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.741 CDS is truncated, and there are 3 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 4-154587520-G-A is Pathogenic according to our data. Variant chr4-154587520-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 402230.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGA | NM_021871.4 | c.502C>T | p.Arg168Ter | stop_gained | 4/5 | ENST00000403106.8 | NP_068657.1 | |
FGA | NM_000508.5 | c.502C>T | p.Arg168Ter | stop_gained | 4/6 | NP_000499.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGA | ENST00000403106.8 | c.502C>T | p.Arg168Ter | stop_gained | 4/5 | 1 | NM_021871.4 | ENSP00000385981 | ||
FGA | ENST00000651975.2 | c.502C>T | p.Arg168Ter | stop_gained | 4/6 | ENSP00000498441 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151954Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
3
AN:
151954
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251358Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135846
GnomAD3 exomes
AF:
AC:
2
AN:
251358
Hom.:
AF XY:
AC XY:
1
AN XY:
135846
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461698Hom.: 0 Cov.: 33 AF XY: 0.0000151 AC XY: 11AN XY: 727160
GnomAD4 exome
AF:
AC:
21
AN:
1461698
Hom.:
Cov.:
33
AF XY:
AC XY:
11
AN XY:
727160
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151954Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74204
GnomAD4 genome
AF:
AC:
3
AN:
151954
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
74204
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Familial visceral amyloidosis, Ostertag type;C0272350:Familial dysfibrinogenemia;C2584774:Congenital afibrinogenemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 02, 2021 | - - |
Congenital afibrinogenemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Sep 26, 2015 | The c.502C>T, p.Arg168ter variant has been seen in the homozygous state in four individuals: one Norwegian (Fellowes et al., 2000) and three Sardinian (Asselta et al., 2001), who were diagnosed with congenital afibrinogenemia. All these individuals had immunologically very low; to undetectable fibrinogen levels suggesting that loss-of-function is a mechanism of disease. Furthermore, this variant was shown to co-segregate with disease and family members who were heterozygous for this variant were unaffected (Fellowes et al., 2000). Arginine at position 168 is evolutionarily conserved and it is present within the coil-coil domain of the protein. This domain is critical for protein assembly. Indeed, an in vitro study using the p.Arg168ter variant showed an absence of secreted fibrinogen because of its inability to assemble with the other fibrinogen subunits (β and γ) (Asselta et al., 2001). This variant is either absent or present at a very low frequency, with no homozygotes, in the population databases (1000 Genome, Exome Sequencing Project and ExAC). In summary, this variant meets our criteria for a Pathogenic classification. We have confirmed this finding in our laboratory using Sanger sequencing. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 06, 2017 | For these reasons, this variant has been classified as Pathogenic. Analysis of patient-derived plasma was unable to detect fibrinogen via clotting and immunological methods in an individual carrying this variant along with another rare FGA variant (PMID: 26763372). This variant has been reported in the homozygous or compound heterozygous state in individuals affected with afibrinogenaemia (PMID: 10887149, 26763372). ClinVar contains an entry for this variant (Variation ID: 402230). This variant is present in population databases (rs755117226, ExAC 0.001%). This sequence change results in a premature translational stop signal in the FGA gene (p.Arg168*). This is expected to delete the last 477 amino acids (~74%) of the FGA protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A;D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at